Found: 1
Select item for more details and to access through your institution.
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 117, doi. 10.3390/vaccines11010117
- By:
- Publication type:
- Article